Advanced search for publications
Enter your keywords
Opioids – MO opportunities
Overview At the end of July 2023 NHSE published guidance titled “National medicines optimisation opportunities 2023/24”. This guidance describes the 16 national medicines optimisation opportunities for the NHS in 2023/24, and signposts to resources to help with their implementation. It recommends Integrated Care Boards (ICBs) choose at least five medicines optimisation opportunities to focus and […]
Diabetes prescribing and outcomes overview – supplementary data to Diabetes therapeutic report
Overview Overview of changes in primary care prescribing for the management of diabetes and trends in hospital admissions outcomes data for the diabetic patient population. This is a supplementary data report to be used alongside the Diabetes therapeutic report to support understanding of the impact of diabetes prescribing and interventions, alongside monitoring patient population health […]
Financial Headline Summary Reports
These pdf reports summarise the headline information from the Monthly Financial Headlines, Top 50 BNF Sections and Drugs and Price Concessionary bulletin reports at SICBL, ICB, regional and national level. Copies of this report are available on request via nuth.nyrdtc.rxsupp@nhs.net. A version of the report showing the data for the 7 commissioning regions with England […]
Price Concessionary Bulletin
The purpose of this bulletin is to present the predicted cost impact of drug price changes, both through the Price Concessions list and also monthly drug tariff (DT) cost variations. The data is calculated by matching the ePACT2 prescribing data for the latest month available to the current prices listed in the NHSBSA Drug Tariff […]
Blood Glucose Test Strips – MO opportunities
Overview At the end of July 2023 NHSE published guidance titled “National medicines optimisation opportunities 2023/24”. This guidance describes the 16 national medicines optimisation opportunities for the NHS in 2023/24, and signposts to resources to help with their implementation. It recommends Integrated Care Boards (ICBs) choose at least five medicines optimisation opportunities to focus and […]
Sodium Valproate – MO opportunities
Overview At the end of July 2023 NHSE published guidance titled “National medicines optimisation opportunities 2023/24”. This guidance describes the 16 national medicines optimisation opportunities for the NHS in 2023/24, and signposts to resources to help with their implementation. It recommends Integrated Care Boards (ICBs) choose at least five medicines optimisation opportunities to focus and […]
Polypharmacy – MO opportunities
Overview At the end of July 2023 NHSE published guidance titled “National medicines optimisation opportunities 2023/24”. This guidance describes the 16 national medicines optimisation opportunities for the NHS in 2023/24, and signposts to resources to help with their implementation. It recommends Integrated Care Boards (ICBs) choose at least five medicines optimisation opportunities to focus and […]
Top 50 BNF sections and drugs
Frequency Monthly Data period April to July 2026
Monthly Financial Headlines
Overview This report provides headline financial information based on total prescribing for the whole BNF at ICB, sub-ICB and PCN level for the financial year to date with particular focus on cost and item growth compared to the same period from the previous financial year plus financial forecasting. Frequency Monthly Data period July 2026
Cardiovascular – MO opportunities
This report has data at SICBL, ICB and Commissioning Region level and focuses on the cardiovascular MO opportunities: At the end of July 2023 NHSE published guidance titled “National medicines optimisation opportunities 2023/24”. This guidance describes the 16 national medicines optimisation opportunities for the NHS in 2023/24, and signposts to resources to help with their […]